JP2022551199A5 - - Google Patents
Info
- Publication number
- JP2022551199A5 JP2022551199A5 JP2022546592A JP2022546592A JP2022551199A5 JP 2022551199 A5 JP2022551199 A5 JP 2022551199A5 JP 2022546592 A JP2022546592 A JP 2022546592A JP 2022546592 A JP2022546592 A JP 2022546592A JP 2022551199 A5 JP2022551199 A5 JP 2022551199A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- alkyl
- compound according
- cr6r7
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962911648P | 2019-10-07 | 2019-10-07 | |
| US62/911,648 | 2019-10-07 | ||
| PCT/US2020/054393 WO2021071832A1 (en) | 2019-10-07 | 2020-10-06 | Aryl heterobicyclic compounds as kv1.3 potassium shaker channel blockers |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022551199A JP2022551199A (ja) | 2022-12-07 |
| JP2022551199A5 true JP2022551199A5 (cg-RX-API-DMAC7.html) | 2024-05-20 |
| JP7780440B2 JP7780440B2 (ja) | 2025-12-04 |
Family
ID=75438321
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022546592A Active JP7780440B2 (ja) | 2019-10-07 | 2020-10-06 | Kv1.3カリウムシェーカーチャネル遮断薬としてのアリール複素二環式化合物 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230049231A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4041405A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7780440B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220079878A (cg-RX-API-DMAC7.html) |
| CN (1) | CN114828963B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020362118A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112022006292A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3157020A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL291866A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2022004178A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021071832A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116782894A (zh) | 2020-10-06 | 2023-09-19 | D.E.肖研究有限责任公司 | 作为Kv1.3钾Shaker通道阻断剂的内酰胺化合物 |
| US20250230172A1 (en) * | 2021-10-13 | 2025-07-17 | Vanqua Bio, Inc. | Small molecule modulators of glucocerebrosidase activity and uses thereof |
| JP2026513122A (ja) * | 2022-10-28 | 2026-04-23 | 上海深勢唯思科技有限責任公司 | 芳香族複素環式Kv1.3阻害剤、その製造方法及び用途 |
| WO2025021167A1 (zh) * | 2023-07-26 | 2025-01-30 | 上海汇伦医药股份有限公司 | 芳基含氮杂环化合物、药物组合物和应用 |
| WO2025029769A1 (en) | 2023-07-31 | 2025-02-06 | Eli Lilly And Company | Solid forms of a kv1.3 potassium shaker channel blockers and method of using the same |
| WO2025161144A1 (zh) * | 2024-01-29 | 2025-08-07 | 上海深势唯思科技有限责任公司 | 芳基杂环类Kv1.3抑制剂及其制备方法和用途 |
| WO2026021011A1 (zh) * | 2024-07-26 | 2026-01-29 | 浙江海正药业股份有限公司 | 芳基三环类衍生物及其制备方法和用途 |
| TW202607004A (zh) * | 2024-08-01 | 2026-02-16 | 大陸商浙江海正藥業股份有限公司 | 6,7-二氫-5H-吡咯並〔1,2a〕咪唑類衍生物及其製備方法和用途 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3854480A (en) | 1969-04-01 | 1974-12-17 | Alza Corp | Drug-delivery system |
| US4675189A (en) | 1980-11-18 | 1987-06-23 | Syntex (U.S.A.) Inc. | Microencapsulation of water soluble active polypeptides |
| US4452775A (en) | 1982-12-03 | 1984-06-05 | Syntex (U.S.A.) Inc. | Cholesterol matrix delivery system for sustained release of macromolecules |
| US5075109A (en) | 1986-10-24 | 1991-12-24 | Southern Research Institute | Method of potentiating an immune response |
| US5133974A (en) | 1989-05-05 | 1992-07-28 | Kv Pharmaceutical Company | Extended release pharmaceutical formulations |
| US5407686A (en) | 1991-11-27 | 1995-04-18 | Sidmak Laboratories, Inc. | Sustained release composition for oral administration of active ingredient |
| US5736152A (en) | 1995-10-27 | 1998-04-07 | Atrix Laboratories, Inc. | Non-polymeric sustained release delivery system |
| US6348486B1 (en) * | 2000-10-17 | 2002-02-19 | American Home Products Corporation | Methods for modulating bladder function |
| JP4377231B2 (ja) * | 2001-11-05 | 2009-12-02 | 大日本住友製薬株式会社 | 新規なカルバペネム化合物 |
| US6939968B2 (en) * | 2002-12-23 | 2005-09-06 | Bristol-Myers Squibb Company | Atropisomers of 3-substituted-4-arylquinolin-2-one derivatives |
| CN1856477A (zh) * | 2003-09-23 | 2006-11-01 | 默克公司 | 异喹啉钾通道抑制剂 |
| US7538110B2 (en) * | 2005-10-27 | 2009-05-26 | Adolor Corporation | Opioid antagonists |
| TWI370130B (en) * | 2005-11-24 | 2012-08-11 | Eisai R&D Man Co Ltd | Two cyclic cinnamide compound |
| TW201026708A (en) * | 2008-12-12 | 2010-07-16 | Solvay Pharm Bv | Spiro azepane-oxazolidinones as Kv1.3 potassium channel blockers |
| WO2011073273A1 (en) * | 2009-12-16 | 2011-06-23 | Evotec Ag | Benzoxazine aryl sulfonamide derivatives as kv1.3 modulators |
| WO2012155199A1 (en) * | 2011-05-16 | 2012-11-22 | Bionomics Limited | Amine derivatives as potassium channel blockers |
-
2020
- 2020-10-06 KR KR1020227013487A patent/KR20220079878A/ko not_active Withdrawn
- 2020-10-06 EP EP20873621.5A patent/EP4041405A4/en active Pending
- 2020-10-06 JP JP2022546592A patent/JP7780440B2/ja active Active
- 2020-10-06 IL IL291866A patent/IL291866A/en unknown
- 2020-10-06 MX MX2022004178A patent/MX2022004178A/es unknown
- 2020-10-06 US US17/766,834 patent/US20230049231A1/en active Pending
- 2020-10-06 WO PCT/US2020/054393 patent/WO2021071832A1/en not_active Ceased
- 2020-10-06 BR BR112022006292A patent/BR112022006292A2/pt not_active IP Right Cessation
- 2020-10-06 CA CA3157020A patent/CA3157020A1/en active Pending
- 2020-10-06 CN CN202080084787.8A patent/CN114828963B/zh active Active
- 2020-10-06 AU AU2020362118A patent/AU2020362118A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022550640A5 (cg-RX-API-DMAC7.html) | ||
| JP2022551197A5 (cg-RX-API-DMAC7.html) | ||
| JP2022552445A5 (cg-RX-API-DMAC7.html) | ||
| JP2022550641A5 (cg-RX-API-DMAC7.html) | ||
| CA2563895C (en) | Disalt inhibitors of il-12 production | |
| JP2019521984A5 (cg-RX-API-DMAC7.html) | ||
| CA2486537A1 (en) | 4-(substituted cycloalkylmethyl)imidazole-2-thiones, 4-(substituted cycloalkenylmethyl)imidazole-2-thiones, 4-(substituted cycloalkylmethyl)imidazol-2-ones and 4-(substituted cycloalkenylmethyl)imidazol-2-ones and related compounds | |
| JP2024512931A5 (cg-RX-API-DMAC7.html) | ||
| EP4041230A1 (en) | Arylmethylene aromatic compounds as kv1.3 potassium shaker channel blockers | |
| CN103781763B (zh) | 作为钾通道阻断剂的胺衍生物 | |
| CN117500785A (zh) | 用于治疗神经退化性疾病的含羧酸氮杂环丁烷基化合物 | |
| EA034015B1 (ru) | Модуляторы р2х7 | |
| CN118632834A (zh) | 用于治疗神经变性疾病的含有羧酸的茚满基化合物 | |
| CN115667236A (zh) | 1,5-二氢-2,4-苯二氮䓬-3-酮衍生物及其应用 | |
| KR20230124992A (ko) | 신경변성 질환의 치료를 위한 카르복실산 함유 인다닐화합물 | |
| WO2022217118A1 (en) | Pyrimidine based ras modulators and uses thereof | |
| US11136330B2 (en) | Synthesis of labeled imidazo[1,2-A]pyrimidines | |
| JP2022551198A5 (cg-RX-API-DMAC7.html) | ||
| CN111434653A (zh) | 三氮唑类化合物及其制备方法与用途 | |
| JP2022526015A5 (cg-RX-API-DMAC7.html) | ||
| JP2024525150A5 (cg-RX-API-DMAC7.html) | ||
| CN115667272A (zh) | 一类jak激酶抑制剂及其制备和应用 | |
| EP3577114A1 (de) | Verfahren zur herstellung halogenierter imidazopyridinderivate | |
| WO2024019957A1 (en) | Compounds for the treatment of neurodegenerative diseases | |
| RU2024124449A (ru) | Спироциклические пиперидинильные производные в качестве ингибиторов фактора b системы комплемента и их варианты применения |